Chemicals

T-butyl-(3R,5S)-6-hydroxy 3,5-O-isopropylidene 3,5-dihydroxyhexanoate

We are T-butyl-(3R,5S)-6-hydroxy 3,5-O-isopropylidene 3,5-dihydroxyhexanoate CAS:124655-09-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:T-butyl-(3R,5S)-6-hydroxy 3,5-O-isopropylidene 3,5-dihydroxyhexanoate

CAS.NO:124655-09-0

Synonyms:T-butyl-(3R,5S)-6-hydroxy 3,5-O-isopropylidene 3,5-dihydroxyhexanoate

(4R-Cis)-6-Hydroxymethyl-2,2-Dimethyl-1,3-Dioxane-4-Acetic Acid 1,1-Dimethylethyl Ester

2-Methyl-2-propanyl 2,4-dideoxy-3,5-O-isopropylidene-D-erythro-hexonate

1,1-Dimethylethyl 2,4-dideoxy-3,5-O-(1-methylethylidene)-D-erythro-hexonoate

(4R,6S)-6-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester

2-[(4R,6S)-6-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetic Acid tert-Butyl Ester

tert-Butyl 2,4-dideoxy-3,5-O-isopropylidene-D-erythro-hexonate

Physical and Chemical Properties:

Density 1.0±0.1 g/cm3

Boiling Point 330.9±17.0 °C at 760 mmHg

Molecular Formula C13H24O5

Molecular Weight 260.327

Flash Point 113.1±14.4 °C

Vapour Pressure 0.0±1.6 mmHg at 25°C

Index of Refraction 1.442

Specification:

Appearance:Yellow to brown oil liquid

Assay:≥98.0%

Packing:200 kg/drum, can also be packaged according to customer requirements

Storage:Store in a cool, ventilated place

Application:Intermediate of Rosuvastatin calcium(CAS:147098-20-2).

T-butyl-(3R,5S)-6-hydroxy 3,5-O-isopropylidene 3,5-dihydroxyhexanoate

Related News: Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.4-Fluorobenzoyl chloride CAS:403-43-0 Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.(R) -5-Bromo-3 – [(1-metil-2-pirrolidinil) metil] -1H-indol CAS:143322-57-0 Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.22128-62-7 China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.

Product Name
methyl (1R,2S)-1-amino-2-ethenylcyclopropane-1-carboxylate,hydrochloride	View Details
3-Fluoro-4-nitrophenol	View Details
Vanadium(V) Trichloride Oxide Cas:7727-18-6	View Details